Late endocrine effects of childhood cancer (Q38794942)

6 September 2017

Late endocrine effects of childhood cancer (English)

1 reference

6 September 2017

1 reference

Susan R Rose

1

1 reference

6 September 2017

Vincent E Horne

2

1 reference

6 September 2017

Jonathan Howell

3

1 reference

6 September 2017

Sarah A Lawson

4

1 reference

6 September 2017

Meilan M Rutter

5

1 reference

6 September 2017

Gylynthia E Trotman

6

1 reference

6 September 2017

Sarah D Corathers

7

1 reference

6 September 2017

1 April 2016

1 reference

Nature Reviews Endocrinology

6 September 2017

1 reference

6 September 2017

12

1 reference

6 September 2017

6

1 reference

6 September 2017

319-336

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2016.45

6 September 2017

0 references

cites work

Survivors of childhood and adolescent cancer: life-long risks and responsibilities.

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Clinical ascertainment of health outcomes among adults treated for childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Cancer survivorship: a pediatric perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine late effects of childhood cancer therapy: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Long-term endocrine sequelae of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine complications in long-term survivors of childhood cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The late effects of childhood cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Fertility preservation for young patients with cancer: who is at risk and what can be offered?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Dose-Effect Relationship of Alkylating Agents on Testicular Function in Male Survivors of Childhood Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Chemotherapy-induced ovarian failure: manifestations and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: Comparison of fracture risk with the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Bone mineral density in young adult survivors of acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Little evidence of low bone mass in acute lymphoblastic leukemia survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Late effects and quality of life of childhood cancer survivors: Part 2. Impact of radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Differential effects of radiotherapy on growth and endocrine function among acute leukemia survivors: a childhood cancer survivor study report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Age at menarche in childhood cancer survivors: results of a nationwide survey in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine outcome in long-term survivors of childhood brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Adrenal function testing in pediatric cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Risk factors for the development of obesity in children surviving brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Improved diagnosis of mild hypothyroidism using time-of-day normal ranges for thyrotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Hyperparathyroidism after irradiation for childhood malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Adult height and adult sitting height in childhood medulloblastoma survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine sequelae of cancer and cancer treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Hematopoietic stem cell transplantation and immunotherapy for pediatric acute myeloid leukemia: an open challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine sequelae and metabolic syndrome in adult long-term survivors of childhood acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Morbidity and tumor-related mortality among adult survivors of pediatric brain tumors: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Restoration of ovarian function after chemotherapy for osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Long-term follow-up status of patients with neuroblastoma after undergoing either aggressive surgery or chemotherapy--a single institutional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine disorders: causes of hyponatremia not to neglect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Chronic neuroendocrinological sequelae of radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Differential radiosensitivity of hypothalamo-pituitary function in the young adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Radiation-induced hypopituitarism after cancer therapy: who, how and when to test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Reduced pulsatile growth hormone secretion in children after therapy for acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Growth and neuroendocrine dysfunction following therapy for childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Growth hormone deficiency after treatment of acute leukaemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Radiation and pituitary dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The dynamics of growth hormone (GH) secretion in adult cancer survivors with severe GH deficiency acquired after brain irradiation in childhood for nonpituitary brain tumors: evidence for preserved pulsatility and diurnal variation with increased se

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The Advantage of Measuring Stimulated as Compared with Spontaneous Growth Hormone Levels in the Diagnosis of Growth Hormone Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Growth hormone therapy in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Pharmacodynamic considerations with recombinant human insulin-like growth factor-I in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Pituitary dysfunction in adult patients after cranial irradiation for head and nasopharyngeal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Improvement in cardiac systolic function and reduced prevalence of metabolic syndrome after two years of growth hormone (GH) treatment in GH-deficient adult survivors of childhood-onset acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Incidence of primary cancers and intracranial tumour recurrences in GH-treated and untreated adult hypopituitary patients: analyses from the Hypopituitary Control and Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Impact of adult growth hormone deficiency on daily functioning and well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

ACTH deficiency in childhood cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Hypothalamic-pituitary dysfunction after radiation for brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Age at onset of puberty following high-dose central nervous system radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Abnormal timing of menarche in survivors of central nervous system tumors: A report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The timing of puberty: is it changing? Does it matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Clinical practice. Precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Consensus statement on the use of gonadotropin-releasing hormone analogs in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The histrelin implant: a novel treatment for central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Fertility considerations and preservation in haemato-oncology patients undergoing treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Understanding Fertility in Young Female Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Testicular tissue cryopreservation and spermatogonial stem cell transplantation to restore fertility: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Effect of graded doses of ionizing radiation on the human testis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Leydig cell function and radiation: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Follicle dynamics during ovarian ageing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Committee opinion no. 618: Ovarian reserve testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Clinical practice. Primary ovarian insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Primary ovarian insufficiency: a more accurate term for premature ovarian failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Acute ovarian failure in the childhood cancer survivor study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Anti-Müllerian Hormone Is a Marker for Chemotherapy-Induced Testicular Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Inhibin B as a marker of sertoli cell damage and spermatogenic disturbance in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Anti-Müllerian hormone in men with normal and reduced sperm concentration and men with maldescended testes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Hormone replacement therapy for the adolescent patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

What is the optimal therapy for young males with hypogonadotropic hypogonadism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Moving toward an understanding of hormone replacement therapy in adolescent girls: looking through the lens of Turner syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Ovarian tissue cryopreservation for fertility preservation in cancer patients: successful establishment and feasibility of a multidisciplinary collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Perceptions of Infertility Risks Among Female Pediatric Cancer Survivors Following Gonadotoxic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

'An ounce of prevention is worth a pound of cure': the case for and against GnRH-agonist for fertility preservation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Gonadotrophin replacement for induction of fertility in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Premature ovarian insufficiency: how to improve reproductive outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Utility of gonadotropin-releasing hormone agonists for fertility preservation in young breast cancer patients: the benefit remains uncertain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Ovarian stimulation and in-vitro fertilization outcomes of cancer patients undergoing fertility preservation compared to age matched controls: a 17-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Fertility preservation in female cancer patients: An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

New advances in ovarian autotransplantation to restore fertility in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Ovarian tissue banking for cancer patients: fertility preservation, not just ovarian cryopreservation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Conservative treatment of reproductive and sexual function in young woman with squamous carcinoma of the vagina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Cryopreservation of semen from pubertal boys with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Sexual function in childhood cancer survivors: a report from Project REACH

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Sexual functioning in young adult survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Sexual dysfunction and infertility as late effects of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The biology of graft-versus-host disease: experimental systems instructing clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Female genital chronic graft-versus-host disease: importance of early diagnosis to avoid severe complications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Assessment of sexual dysfunction in patients with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Validated instruments for assessing female sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Fractures among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Modifiable risk factors associated with bone deficits in childhood cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Prevalence of vitamin D insufficiency in survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Vitamin D Deficiency and Survival in Children after Hematopoietic Stem Cell Transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The metabolic syndrome in cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Metabolic syndrome in adult survivors of childhood cancer: the intersection of oncology, endocrinology, and cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Hypothalamic obesity in children: pathophysiology to clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Role of the efferent and afferent vagus nerve in the development of ventromedial hypothalamic (VMH) obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The role of vagally-medicated hyperinsulinemia in hypothalamic obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The effects of subdiaphragmatic vagotomy in rats with ventromedial hypothalamic obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Evaluation of a comprehensive care clinic model for children with brain tumor and risk for hypothalamic obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Cardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Current status of transition preparation among youth with special needs in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Supporting the health care transition from adolescence to adulthood in the medical home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Long-term follow-up of survivors of childhood cancer (SIGN Clinical Guideline 132)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Development of a Primary Care-Based Clinic to Support Adults With a History of Childhood Cancer: The Tactic Clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Fertility of long-term male survivors of acute lymphoblastic leukemia diagnosed during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Cancer survivorship--pediatric issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

[Endocrine sequelae after radiotherapy in childhood and adolescence]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Testicular morphological changes in children with acute lymphoblastic leukemia following chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Committee opinion no. 605: primary ovarian insufficiency in adolescents and young women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Craniopharyngioma and hypothalamic obesity in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Primary hyperparathyroidism with a history of head and neck irradiation: the consequences of associated thyroid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the childhood cancer survivor study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Late effects of treatment in survivors of childhood acute myeloid leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Outcomes of growth hormone replacement therapy in survivors of childhood acute lymphoblastic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Update of guidelines for the use of growth hormone in children: the Lawson Wilkins pediatric endocrinology society drug and therapeutics committee

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Isolated central hypothyroidism in short stature

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Precocious puberty and normal variant puberty: definition, etiology, diagnosis and current management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Committee opinion no. 607: Gynecologic concerns in children and adolescents with cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Treatment of infertility with hypogonadotropic hypogonadism: 10-year experience in Auckland, New Zealand

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Abdominal irradiation in childhood; the potential for pregnancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Laparoscopic unilateral ovarian transposition prior to irradiation: prospective study of 20 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Bone health in survivors of childhood cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

The diagnosis of osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Reduced beta-cell reserve and pancreatic volume in survivors of childhood acute lymphoblastic leukaemia treated with bone marrow transplantation and total body irradiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Delayed ghrelin suppression following oral glucose tolerance test in children and adolescents with hypothalamic injury secondary to craniopharyngioma compared with obese controls

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Effects of methylphenidate on weight gain and food intake in hypothalamic obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Outcome after bariatric surgery in two adolescents with hypothalamic obesity following treatment of craniopharyngioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2016.45

Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism

31 March 2020

1 reference

12 December 2020

Effects of Luteinizing Hormone-Releasing Hormone Analog-Induced Pubertal Delay in Growth Hormone (GH)-Deficient Children Treated with GH: Preliminary Results1

1 reference

12 December 2020

Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society

1 reference

12 December 2020

Effects of cranial irradiation on hypothalamic-pituitary function--a 5-year longitudinal study in patients with nasopharyngeal carcinoma

1 reference

12 December 2020

Surgical correction of postradiation spinal deformity.

1 reference

12 December 2020

Cranial irradiation and early puberty.

1 reference

12 December 2020

Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity

1 reference

12 December 2020

Cancer survivors and infertility: a review of a new problem and novel answers.

1 reference

12 December 2020

GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults

1 reference

12 December 2020

Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome.

1 reference

12 December 2020

Diagnosis of hidden central hypothyroidism in survivors of childhood cancer

1 reference

12 December 2020

Endocrine complications of childhood cancer therapy: evaluation and management

1 reference

12 December 2020

Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study

1 reference

12 December 2020

Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2016.45

1 reference

6 September 2017

1 reference